OSR HEALTH, INC. Earnings Per Share (Diluted)
OSR HEALTH, INC. (OSRH) reported Earnings Per Share (Diluted) of -$0.10 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- OSR HEALTH, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.03.
- OSR HEALTH, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.08.
- OSR HEALTH, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.23.
- OSR HEALTH, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.09.
- OSR HEALTH, INC. earnings per share, diluted for fiscal 2025 was -$0.80.
- OSR HEALTH, INC. earnings per share, diluted for fiscal 2024 was -$4.79, a 9680.00% decline from fiscal 2023.
- OSR HEALTH, INC. earnings per share, diluted for fiscal 2023 was $0.05.
- OSR HEALTH, INC. earnings per share, diluted for fiscal 2022 was -$0.01.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.10 10-Q · filed 2026-08-14 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2026-03-31 | -$0.08 10-Q · filed 2026-05-13 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.80 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $0.09 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.57 10-Q · filed 2025-11-12 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-06-30 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.10 10-Q · filed 2026-08-14 | -$0.69 10-Q · filed 2025-08-14 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-03-31 | -$1.04 10-Q · filed 2026-05-13 | -$1.95 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$2.82 derived: net income ÷ weighted average shares · filed 2026-05-13 | ||||
| 2024-12-31 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.52 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$4.79 10-K · filed 2026-03-31 | -$0.54 10-K · filed 2025-04-22 | |||
| 2024-09-30 | -$0.06 10-Q · filed 2024-11-14 | -$4.17 10-Q · filed 2025-11-12 | -$0.08 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | -$0.02 10-Q · filed 2024-08-19 | -$1.00 10-Q · filed 2025-08-14 | -$0.03 10-Q · filed 2024-08-19 | ||||
| 2024-03-31 | -$0.01 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | $0.05 10-K · filed 2025-04-22 | ||||||
| 2023-09-30 | $0.01 10-Q · filed 2024-11-14 | $0.03 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | $0.03 10-Q · filed 2024-08-19 | $0.06 10-Q · filed 2024-08-19 | |||||
| 2023-03-31 | $0.02 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | -$0.01 10-K · filed 2024-04-17 | ||||||
| 2022-09-30 | -$0.01 10-Q · filed 2023-11-07 | -$0.01 10-Q · filed 2023-11-07 | |||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |